TransCelerate launches two new initiatives to accelerate clinical trials

By Zachary Brennan

- Last updated on GMT

TransCelerate launches two new initiatives to accelerate clinical trials

Related tags Clinical trial

Industry group TransCelerate BioPharma has established two new global initiatives around placebo and standard of care data sharing, and electronic labels for clinical trials – both of which aim to accelerate and enhance trials. 

The placebo/standard of care initiative seeks to create a framework to allow for data sharing to reduce the patient population needed to be enrolled in a clinical trial. The sharing of data would also help to decrease the time spent on cumulative trial execution. It also offers the potential for more rapid understanding of safety signals to better manage patient safety, as well as to identify statistical techniques that may deliver more accurate study design and statistical power calculations.

Ulo Palm, SVP, Head of Global Brands Drug Development Operations at Actavis, and TransCelerate Executive Sponsor for the initiative said, “Providing this platform to Member Company biostatisticians may lead to improved protocol development, reduction in protocol amendments and a better understanding of disease models to identify the right targets, including rare disease models​."

Ed Bowen, Senior Director, Translational and Bioinformatics at Pfizer and the lead of this initiative, added, “Pooling this data among TransCelerate member companies has the potential to be powerful and is representative of TransCelerate's overall mission, which is to provide efficient, effective and high quality outcomes for the larger clinical ecosystem through member company collaboration​."

TransCelerate member companies include nearly all of the top biopharma companies, including Pfizer, Roche, Sanofi, GlaxoSmithKline and Eli Lilly. A TransCelerate spokeswoman told Outsourcing-Pharma.com: "We have just completed a Request For Proposal (RFP) process and selected a partner for mapping and hosting the data. We expect to have data available for sharing in Q3 of 2015​."


The other recently announced initiative – the e-Labels Initiative -- will support TransCelerate members in establishing an information channel that increases the consistency of labeling approaches for sites and offers the potential to reduce clinical labeling timelines and provides cost efficiencies for sponsors. The Initiative, in collaboration with Regulatory Agencies, will develop guidance to facilitate implementation of e-Labeling.

Craig Lipset, Head of Clinical Innovation at Pfizer, and Executive Sponsor of the TransCelerate e-Labels Initiative, said, “This effort aims to make product information more accessible to patients and to permit deeper engagement during the clinical trial process.”

The time is right for pharma companies to embrace e-labeling as a critical component to their clinical supply chain strategy​,” added Terry Walsh, Head of Comparator Strategy and Planning at GlaxoSmithKline and the lead of this initiative.

Both initiatives come as TransCelerate also looks to tackle investigator selection bias​ and risk-based monitoring​. And although CROs will not become members of TransCelerate​, the Association of Clinical Research Organizations recently opened up ways for CROs to interact with the members-only group. The group is also working with CROs to establish training programs​ for clinical research staff.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more